EXICURE, INC.

XCUR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016
Revenue $9.7M $1.0M
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development $13.1M $13.7M
SG&A Expense $7.0M $3.5M
Operating Income $-10.4M $-16.2M
Operating Margin -107.1% -1,560.0%
Interest Expense $795.0K $724.0K
Pretax Income $-12.0M $-16.9M
Income Tax Expense $0 $0
Net Income $-11.0M $-16.9M
Net Margin -113.3% -1,635.2%
EPS (Basic) $-0.36 $-49.79
EPS (Diluted) $-0.36 $-49.79
Shares Outstanding (Basic) 117.9M 394.9K
Shares Outstanding (Diluted) 117.9M 394.9K
Dividends Per Share
← Newer Page 2 of 2 Older →